Translational pathways for MSC secretome therapies: from bioprocessing to delivery.

Mesenchymal stromal cells (MSCs) are multipotent, fibroblast-like cells known for their paracrine activity rather than long-term engraftment. Their secretome-the ensemble of soluble factors and extracellular vesicles released by these cells-is emergi…

Preview only. Read the full abstract at the source